AUPH Aurinia Pharmaceuticals Inc.

bullish track record → $15.98 -0.16 (-1.0%)
Get emailed when AUPH changes direction
Mkt Cap $2B P/E 7.7 fwd 19.5 52wk $7.29 - $16.54 Earnings 2026-05-11 52d ago
Insider buying: $115,738,732 bought by 24 insiders (30d)
Factor divergence: DIVERGENCE: insider_activity bullish vs estimate_revisions, analyst_revisions bearish
Est. revisions: -8.1%
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net -1.9)

Factor Model

net -1.9 4.5 / 10
Est. Revisions
-0.5
Insider Activity
+0.5
Momentum
+0.0
Analyst Rev.
-1.0
Narrative Gap
+0.0

Aurinia Posts 25% LUPKYNIS Growth, Guides 11-15% Higher 2026

Watch: Monitor 2026 quarterly trends to confirm the company is tracking within guidance. If LUPKYNIS net product sales growth slips below 12% in H1 2026, it signals earlier-than-expected plateau, which could pressure the narrative and multiple.

Aurinia Pharmaceuticals delivered 2025 revenue of $283.1M, up 20% YoY, with its flagship LUPKYNIS (lupus nephritis treatment) driving the momentum at 25% growth to $271.3M. The company's 2026 guidance calls for $315-$325M in revenue, representing 11-15% growth, suggesting the lupus franchise is maturing but still expanding. Management returned $98.2M to shareholders via buyback and ended the year with $398.0M in cash — enough runway to fund operations and strategic moves without immediate capital needs.

Aurinia has shifted from growth story to steady cash generator. Revenue beats and raised guidance validate LUPKYNIS penetration in a large, underpenetrated market (lupus nephritis affects roughly 50,000 patients in the US). The slowdown from 25% to low double-digit guidance reflects market saturation risk, but the company's strong balance sheet and profitable operations give it optionality — either to reinvest in pipeline depth or continue shareholder returns.

Evidence

4d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $969,476
4d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $978,290
4d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $1,238,407
4d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $1,537,477
4d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $1,895,760
12d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $943,752
12d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $1,693,980
12d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $1,867,389
7 older signals
12d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $1,360,221
12d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $1,819,740
12d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $1,813,811
12d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $1,735,998
12d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $2,403,391
12d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $1,622,791
12d ago Insider buy by Aurinia Pharmaceuticals (AUPH): $1,633,798
Fundamentals & Data ▾
Aurinia Pharmaceuticals Inc. Healthcare · Biotechnology
Mkt Cap
$2B
P/E
7.7 fwd 19.5
Beta
1.52
52w Range
$7.29 - $16.54
Short Interest
10.8M 8.9%
Days to Cover
9.0 +11%
Technicals downtrend
from 52w Hi
-2.7%
1w return
-0.4%
Insiders
buying 19B / 0S
EPS Estimate
$0.20 -8.1% 30d 0up / 1dn
Est. Dispersion
46% 4 analysts
Analyst Target
$17 $15 - $21
Options P/C
0.12
Insider Cluster
strong sell 1B / 13S
Fund Convergence
strong Renaissance, Two Sigma, Citadel, D.E. Shaw
Financials
Revenue
$77M +29% YoY
FCF
$46M
Gross Margin
89%
Op Margin
43%
Momentum: accelerating
Top Holders
Renaissance $25M
Two Sigma $21M
Citadel $16M
D.E. Shaw
Recent Filings & Data
insider trade 143
net buying · $6,462,184 sold · $115,738,732 bought
24 insiders · 143 transactions (30d)
Recent transactions
TANG KEVIN C · buy · $12,688,806
KEENAN GREG · award
MILLER JOSEPH M · award
GREENLEAF PETER S · award
DONLEY MATTHEW MAXWELL · award
ROBERTSON STEPHEN P · award
MILLER JOSEPH M · award
GREENLEAF PETER S · award
DONLEY MATTHEW MAXWELL · award
ROBERTSON STEPHEN P · award
TANG KEVIN C · buy · $13,590,000
KEENAN GREG · sell · $210,000
KEENAN GREG · sell · $68,350
TANG KEVIN C · buy · $12,713,126
MILLER JOSEPH M · sell · $939,612
GREENLEAF PETER S · sell · $2,871,124
DONLEY MATTHEW MAXWELL · sell · $994,425
ROBERTSON STEPHEN P · sell · $975,223
KEENAN GREG · sell · $97,912
MILLER JOSEPH M · award
GREENLEAF PETER S · award
DONLEY MATTHEW MAXWELL · award
ROBERTSON STEPHEN P · award
KEENAN GREG · award
TANG KEVIN C · buy · $10,822,000
JOHNSON CRAIG A · award
BAILEY JEFFREY ALLEN · award
SMITH KAREN LESLEY M.D. PH.D. · award
JAYNE DAVID ROLAND WALKER · award
LEVERSAGE JILL DIANE · award
BAILEY JEFFREY ALLEN · sell · $38,416
SMITH KAREN LESLEY M.D. PH.D. · sell · $44,182
BAILEY JEFFREY ALLEN · other
SMITH KAREN LESLEY M.D. PH.D. · other
HABIG SCOTT MICHAEL · sell · $96,902
MACKAY-DUNN R HECTOR · sell · $32,316
BILLEN DANIEL · sell · $30,146
JAYNE DAVID ROLAND WALKER · sell · $28,390
LEVERSAGE JILL DIANE · sell · $32,201
BALAKRISHNAN BRINDA · sell · $2,985
Aurinia Pharmaceuticals · buy · $1,854,936
Aurinia Pharmaceuticals · buy · $943,752
Donley (Matthew Maxwell) · other
Aurinia Pharmaceuticals · buy · $1,693,980
Aurinia Pharmaceuticals · buy · $1,867,389
Aurinia Pharmaceuticals · buy · $1,360,221
Aurinia Pharmaceuticals · buy · $1,819,740
Aurinia Pharmaceuticals · buy · $1,813,811
Aurinia Pharmaceuticals · buy · $1,735,998
Aurinia Pharmaceuticals · buy · $2,403,391
Aurinia Pharmaceuticals · buy · $1,622,791
Aurinia Pharmaceuticals · buy · $1,633,798
Aurinia Pharmaceuticals · buy · $1,653,089
Aurinia Pharmaceuticals · buy · $1,597,373
Aurinia Pharmaceuticals · buy · $1,671,018
Aurinia Pharmaceuticals · buy · $2,268,926
Aurinia Pharmaceuticals · buy · $1,517,665
Aurinia Pharmaceuticals · buy · $1,529,004
Aurinia Pharmaceuticals · buy · $1,546,318
Aurinia Pharmaceuticals · buy · $1,478,479
Aurinia Pharmaceuticals · buy · $1,304,162
Keenan (Greg) · other
Aurinia Pharmaceuticals · buy · $1,319,412
Aurinia Pharmaceuticals · buy · $1,285,295
Aurinia Pharmaceuticals · buy · $1,277,342
Tang (Kevin C) · other · $1,800,863
Tang (Kevin C) · other · $818,574
Donley (Matthew Maxwell) · other
Greenleaf (Peter S) · other
Miller (Joseph M) · other
Robertson (Stephen P) · other
Tang (Kevin C) · other · $823,229
Tang (Kevin C) · other · $1,131,215
Tang (Kevin C) · other · $374,199
Tang (Kevin C) · other · $514,188
Aurinia Pharmaceuticals · buy · $1,279,590
Aurinia Pharmaceuticals · buy · $1,392,350
Tang (Kevin C) · other · $2,866,875
Tang (Kevin C) · other · $2,085,552
Tang (Kevin C) · other · $15,818
Tang (Kevin C) · other · $1,303,125
Tang (Kevin C) · other · $947,974
Tang (Kevin C) · other · $7,190
Donley (Matthew Maxwell) · other
Greenleaf (Peter S) · other
Miller (Joseph M) · other
Robertson (Stephen P) · other
Keenan (Greg) · other
Donley (Matthew Maxwell) · other
Donley (Matthew Maxwell) · other
Greenleaf (Peter S) · other
Greenleaf (Peter S) · other
Greenleaf (Peter S) · other
Miller (Joseph M) · other
Miller (Joseph M) · other
Miller (Joseph M) · other
Robertson (Stephen P) · other
Robertson (Stephen P) · other
Robertson (Stephen P) · other
Bailey (Jeffrey Allen) · other
Johnson (Craig A) · other
Tang (Kevin C) · other · $1,313,766
Tang (Kevin C) · other · $1,022,233
Tang (Kevin C) · other · $637,761
Tang (Kevin C) · other · $496,238
Keenan (Greg) · other · $210,000
Tang (Kevin C) · other
Tang (Kevin C) · other · $5,691,488
Tang (Kevin C) · other · $4,428,512
Aurinia Pharmaceuticals · buy · $219,583
Aurinia Pharmaceuticals · buy · $212,504
Aurinia Pharmaceuticals · buy · $525,825
Aurinia Pharmaceuticals · buy · $733,529
Aurinia Pharmaceuticals · buy · $732,438
Aurinia Pharmaceuticals · buy · $651,577
Aurinia Pharmaceuticals · buy · $1,248,514
Aurinia Pharmaceuticals · buy · $1,222,671
Aurinia Pharmaceuticals · buy · $1,024,289
Aurinia Pharmaceuticals · buy · $1,013,890
Aurinia Pharmaceuticals · buy · $1,064,359
Aurinia Pharmaceuticals · buy · $591,744
Aurinia Pharmaceuticals · buy · $442,053
Aurinia Pharmaceuticals · buy · $431,397
Aurinia Pharmaceuticals · buy · $418,507
Aurinia Pharmaceuticals · buy · $415,501
Aurinia Pharmaceuticals · buy · $810,165
Aurinia Pharmaceuticals · buy · $887,918
Aurinia Pharmaceuticals · buy · $905,556
Aurinia Pharmaceuticals · buy · $885,987
Aurinia Pharmaceuticals · buy · $467,059
Aurinia Pharmaceuticals · buy · $568,060
Aurinia Pharmaceuticals · buy · $569,892
Aurinia Pharmaceuticals · buy · $564,486
Aurinia Pharmaceuticals · buy · $563,306
Aurinia Pharmaceuticals · buy · $560,834
Aurinia Pharmaceuticals · buy · $569,036
Aurinia Pharmaceuticals · buy · $572,081
Aurinia Pharmaceuticals · buy · $562,799
Aurinia Pharmaceuticals · buy · $969,476
Aurinia Pharmaceuticals · buy · $1,895,760
Aurinia Pharmaceuticals · buy · $1,537,477
Aurinia Pharmaceuticals · buy · $978,290
Aurinia Pharmaceuticals · buy · $1,238,407
15 signals · latest 4d ago

Get alerted when AUPH changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →